Plague vaccine: recent progress and prospects

W Sun, AK Singh - npj Vaccines, 2019 - nature.com
Three great plague pandemics, resulting in nearly 200 million deaths in human history and
usage as a biowarfare agent, have made Yersinia pestis as one of the most virulent human …

Prospects for new plague vaccines

VA Feodorova, MJ Corbel - Expert review of vaccines, 2009 - Taylor & Francis
The potential application of Yersinia pestis for bioterrorism emphasizes the urgent need to
develop more effective vaccines against airborne infection. The current status of plague …

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection

JS Lin, LW Kummer, FM Szaba… - The Journal of …, 2011 - journals.aai.org
Pneumonic plague is one of the world's most deadly infectious diseases. The causative
bacterium, Yersinia pestis, has the potential to be exploited as a biological weapon, and no …

Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis

CK Cote, SS Biryukov, CP Klimko, JL Shoe, M Hunter… - Vaccines, 2021 - mdpi.com
The etiologic agent of plague, Yersinia pestis, is a globally distributed pathogen which
poses both a natural and adversarial threat. Due largely to the rapid course and high …

A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model

KA Gregg, E Harberts, FM Gardner, MR Pelletier… - Vaccine, 2018 - Elsevier
Vaccination can significantly reduce worldwide morbidity and mortality to infectious
diseases, thereby reducing the health burden as a result of microbial infections. Effective …

IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-γ–activated macrophage programming

Y Bi, J Zhou, H Yang, X Wang, X Zhang… - The Journal of …, 2014 - journals.aai.org
YB designed and did the experiments with cells and mice, analyzed data, and contributed to
writing the manuscript; JZ designed the experiments with mice and contributed to …

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague

JS Lin, S Park, JJ Adamovicz, J Hill, JB Bliska, CK Cote… - Vaccine, 2010 - Elsevier
Immunization with the Yersinia pestis F1 and LcrV proteins improves survival in mouse and
non-human primate models of pneumonic plague. F1-and LcrV-specific antibodies …

TNFα and IFNγ but Not Perforin Are Critical for CD8 T Cell-Mediated Protection against Pulmonary Yersinia pestis Infection

FM Szaba, LW Kummer, DK Duso, EP Koroleva… - PLoS …, 2014 - journals.plos.org
Septic pneumonias resulting from bacterial infections of the lung are a leading cause of
human death worldwide. Little is known about the capacity of CD8 T cell-mediated immunity …

Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not …

W Bowen, L Batra, AR Pulsifer, ES Yolcu, MB Lawrenz… - Vaccine, 2019 - Elsevier
Yersinia pestis is the causative agent of plague and is a re-emerging pathogen that also has
the potential as a biological weapon, necessitating the development of a preventive vaccine …

Absence of Inflammation and Pneumonia during Infection with Nonpigmented Yersinia pestis Reveals a New Role for the pgm Locus in Pathogenesis

H Lee-Lewis, DM Anderson - Infection and immunity, 2010 - Am Soc Microbiol
Yersinia pestis causes primary pneumonic plague in many mammalian species, including
humans, mice, and rats. Virulent Y. pestis strains undergo frequent spontaneous deletion of …